Bifogade filer
Kurs
+1,23%
Likviditet
0,06 MSEK
Kalender
Tid* | ||
2025-07-24 | 07:30 | Kvartalsrapport 2025-Q3 |
2025-04-25 | 07:30 | Kvartalsrapport 2025-Q2 |
2025-01-30 | 07:30 | Kvartalsrapport 2025-Q1 |
2024-11-29 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2024-11-28 | - | Årsstämma |
2024-10-24 | - | Bokslutskommuniké 2024 |
2024-07-25 | - | Kvartalsrapport 2024-Q3 |
2024-05-27 | - | Extra Bolagsstämma 2024 |
2024-04-25 | - | Kvartalsrapport 2024-Q2 |
2024-01-25 | - | Kvartalsrapport 2024-Q1 |
2023-12-01 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2023-11-30 | - | Årsstämma |
2023-10-26 | - | Bokslutskommuniké 2023 |
2023-07-27 | - | Kvartalsrapport 2023-Q3 |
2023-04-27 | - | Kvartalsrapport 2023-Q2 |
2023-01-26 | - | Kvartalsrapport 2023-Q1 |
2022-11-25 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2022-11-24 | - | Årsstämma |
2022-10-27 | - | Bokslutskommuniké 2022 |
2022-07-28 | - | Kvartalsrapport 2022-Q3 |
2022-04-28 | - | Kvartalsrapport 2022-Q2 |
2022-01-27 | - | Kvartalsrapport 2022-Q1 |
2021-11-25 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2021-11-24 | - | Årsstämma |
2021-10-29 | - | Bokslutskommuniké 2021 |
2021-07-30 | - | Kvartalsrapport 2021-Q3 |
2021-04-29 | - | Kvartalsrapport 2021-Q2 |
2021-01-29 | - | Kvartalsrapport 2021-Q1 |
2020-11-25 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2020-11-24 | - | Årsstämma |
2020-10-30 | - | Bokslutskommuniké 2020 |
2020-07-31 | - | Kvartalsrapport 2020-Q3 |
2020-06-03 | - | Extra Bolagsstämma 2020 |
2020-04-30 | - | Kvartalsrapport 2020-Q2 |
2020-01-31 | - | Kvartalsrapport 2020-Q1 |
2019-12-06 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2019-12-05 | - | Årsstämma |
2019-10-31 | - | Bokslutskommuniké 2019 |
2019-07-31 | - | Kvartalsrapport 2019-Q3 |
2019-04-30 | - | Kvartalsrapport 2019-Q2 |
2019-01-31 | - | Kvartalsrapport 2019-Q1 |
2018-12-05 | - | Årsstämma |
2018-11-01 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2018-10-31 | - | Bokslutskommuniké 2017 |
2018-07-31 | - | Kvartalsrapport 2017-Q3 |
2017-12-06 | - | X-dag ordinarie utdelning NXTCL 0.00 SEK |
2017-12-05 | - | Årsstämma |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Today Wednesday on February 14th at 10.30 CET Dr. Mathias Svahn, CEO of NextCell Pharma AB ("NextCell" or the"Company"), will present the latest developments in the company at Redeye.
The presentation is live broadcasted and can be followed at Redeye Theme: Regenerative Medicine/Cell Therapy - Redeye (https://www.redeye.se/events/966283/redeye-theme-cell-therapy) www.redeye.se/events/966283/redeye-theme-cell-therapy where the replay and the presentations will be available afterwards.
Mathias Svahn, CEO
Patrik Fagerholm, CFO
Tel: +46 8 735 55 95
E-mail: info@nextcellpharma.com
Website:www.nextcellpharma.com
Linkedin: https://www.linkedin.com/NextCell-Pharma (https://www.linkedin.com/company/15255207/)
Twitter: https://twitter.com/NextCellPharma
For more information about Cellaviva, please contact
Sofie Falk Jansson, Head of Cellaviva
Tel: +46 8 735 20 10
E-mail: info@cellaviva.se (info@nextcellpharma.com)
Website:www.cellaviva.se (http://www.nextcellpharma.com)
Facebook: https://www.facebook.com/cellavivasverige (https://www.linkedin.com/company/15255207/)
Instagram: https://www,instagram.com/cellaviva (https://twitter.com/NextCellPharma)